The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.

Source:http://linkedlifedata.com/resource/pubmed/id/17908988

Clin. Cancer Res. 2007 Oct 1 13 19 5918-25

Download in:

View as

General Info

PMID
17908988